490.58MMarket Cap-0.41P/E (TTM)
19.500High18.300Low193.94KVolume19.080Open19.020Pre Close3.63MTurnover2.07%Turnover RatioLossP/E (Static)25.73MShares41.87052wk High657.59P/B178.64MFloat Cap11.66552wk Low--Dividend TTM9.37MShs Float728.003Historical High--Div YieldTTM6.31%Amplitude11.665Historical Low18.734Avg Price1Lot Size
Cartesian Therapeutics Stock Forum
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment
Dow Jones· just
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...
No comment yet